The hemp-derived active ingredients provider is expected to more than double 22nd Century’s revenue.Read More
Tags :22nd Century Group
The cannabis plant transformation breakthrough was unlocked by 22nd Century and KeyGene.Read More
"The only public health value of these products is if smokers don’t use them and switch" to vapor.Read More
The deal will assist in the advancement of research and development on the biosynthesis of cannabinoids.Read More
22nd Century has added strategic partnerships with expert commercial-scale plant breeders.Read More
The company will take ownership of Needle Rock Farms and provide a North American cultivation base.Read More
New initiatives support the firm’s plans for multiple avenues of revenue.Read More
CannaMetrix technology will enable 22 Century to reduce the time to bring its IP to the market. Read More
The breakthrough is expected to yield disruptive plant lines and new licensing opportunities.Read More
The new intellectual property facilitates the precise control and modulation of cannabinoid productionRead More
